GINNA PRUTZMAN: Open Payments
NPI 1184210114 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,213 in 104 payments from 34 companies in 2025. Trend: 2023 $279 · 2024 $1,830 · 2025 $2,213
Food & beverage: $2,135Education: $78
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $277 |
| Incyte Corporation | 10 | $224 |
| Novartis Pharmaceuticals Corporation | 9 | $218 |
| Regeneron Healthcare Solutions, Inc. | 9 | $179 |
| PharmaEssentia USA Corporation | 2 | $152 |
| Genentech USA, Inc. | 6 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $103 |
| AstraZeneca Pharmaceuticals LP | 6 | $101 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| Daiichi Sankyo Inc. | 4 | $76 |
Products named: LIBTAYO, BESREMI, MONJUVI, TALVEY, ERLEADA, REBLOZYL, Epkinly, Nubeqa.
Industry payments across AL — which companies pay providers there.
